These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. Fernandez-Guerrero M, Rouse M, Henry N, Wilson W. Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989 [Abstract] [Full Text] [Related]
13. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Karchmer AW. Am J Med; 1985 Jun 28; 78(6B):116-27. PubMed ID: 3893113 [Abstract] [Full Text] [Related]
14. Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. Dworkin R, Modin G, Kunz S, Rich R, Zak O, Sande M. Antimicrob Agents Chemother; 1990 Jun 28; 34(6):1014-6. PubMed ID: 2393259 [Abstract] [Full Text] [Related]
17. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C. Antimicrob Agents Chemother; 1999 Nov 28; 43(11):2742-6. PubMed ID: 10543757 [Abstract] [Full Text] [Related]